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Chagas disease presents bio-psycho-social and cultural determinants for infected patients,
their family members, close friends, and society. For this reason, diagnosis and treatment
require an active approach and an integral focus, so that we can prevent the disease from
creating stigma and exclusion, as is actively promoting access to diagnosis, medical atten-
tion and social integration
Methodology
The study was conducted in the Metropolitan Area of Barcelona (Catalonia, Spain) from
2004 to 2017. After an increased detection rates of CHD in our region, the process of con-
struction of community strategies started (2004–2013). Different community interventions
with informational, educational, and communication components were designed, devel-
oped, implemented, and evaluated. The results of the evaluation helped to determine which
intervention should be prioritized: 1) workshop; 2) community event; 3) in situ screening.
Afterwards, those strategies were implemented (2014–2017).
Results
Each of the three strategies resulted in a different level of coverage, or number of people
reached. The in situ screening interventions reached the highest coverage (956 persons,
58.98%).Clear differences exist (p-value<0.001) between the three strategies regarding the
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percentage of screenings and diagnoses carried out. The largest number was in the in situ
screening intervention, with a total of 830 persons screened despite the greatest number of
diagnoses was among the workshop participants (33 persons, 20.75% of those screened).
The prevalence of infection found is similar among the three strategies, ranging from
16.63% to 22.32% of the screened patients (p-value = 0.325).
Conclusions
The results of the study show that community interventions seem to be necessary to
improve access to diagnosis and treatment of CHD in the area of Barcelona. They also
show which strategy is the most appropriate based on the detected needs of the community,
the proposed objectives of the intervention, and the given socio-temporal context.
Introduction
Chagas disease (CHD) is a disease caused by the parasite Trypanosoma cruzi. According to
estimates by the World Health Organization (WHO), there are currently between 6 and 7 mil-
lion infected people, predominantly in the continental territory of 21 Latin American coun-
tries [1]. As a consequence of population movement, mainly migration, a growing number of
cases have been detected in recent decades in Canada and the United States of America, in 17
European countries, and in two in the West Pacific, characterizing a new epidemiological dis-
tribution worldwide [1,2]. In fact, CHD is, nowadays, a predominantly urban disease (two
thirds of infected patients live in cities) and the means of non-vectorial transmission have
acquired greater relevance [1,2]. It is estimated that in reality up to 75 million people in the
world are at risk of infection [1].
In 2015 the WHO included CHD among the 21 Neglected Tropical Diseases and, like the
others, one of the main challenges of its control is the detection of undiagnosed cases, estimat-
ing that worldwide, no more than 10% of infected patients have been diagnosed [1,3].
The biomedical, psycho-social, cultural, and anthropological characteristics of CHD are
important determinants for those infected, their family members, and the society that sur-
rounds them [4,5]. There are multiple complex barriers faced by migrant populations regard-
ing access to CHD diagnosis and treatment. Psycho-social barriers, such as fear of the disease
and stigma, are the most relevant. Other barriers are administrative, such difficulties accessing
healthcare services [4–8]. An integral approach keeping these determinants in mind is essential
for promoting access to diagnosis and treatment, along with social integration and prioritizing
the elimination of the various personal and social barriers that characterize the disease [6–8].
In the recent years, approaches based on information, education, and communication have
included the key analytical elements that are necessary to understand CHD and the problems
that infected people face. These approaches have brought new perspectives that are both differ-
ent and constructive to the families and close friends of patients, and to the community [7–9].
In addition, multiple decisive actions have recently been carried out by different stakehold-
ers in the fields of public health, health systems, and the academic and research world, along
with civil society (including those lead by different groups of people affected by CHD). These
actions aimed to achieve better visibility, awareness, and promotion of access to diagnosis,
treatment, and globally-applied research. One of the recent and most relevant initiatives was
the creation of the International Federation of Associations of People Affected by Chagas Dis-
ease (FINDECHAGAS), in 2010 in Olinda (State of Pernambuco, Brazil), which today brings
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together more than 20 associations of affected people in the Americas, Europe, and the West
Pacific.
In this context, the Public Health and Community team (eSPiC) of the Drassanes-Vall
d’Hebron International Health Unit Drassanes-Vall d’Hebron (USIDVH), of the International
Health Program of the Catalan Institute of Health—PROSICS, has worked in the community
field since the year 2004 carrying out interventions that look to improve detection and access
to diagnosis and treatment of CHD.
This article describes the experience of the first 13 years of this team’s work. First, the pro-
cess of construction of the community strategies is explained, describing the design, develop-
ment and implementation of the strategies. Afterwards, the resulting strategies are compared
and evaluated.
Methodology
The study is divided into two periods of time: the first one between 2004 and 2013, in which
the community work process is built; and the second period from 2014 to 2017, in which three
different community interventions about this population are implemented and evaluated.
Area and period of the study
This work was conducted in the Metropolitan Area of Barcelona (Catalonia, Spain). In Catalo-
nia in the year 2017, there were 7,555,830 inhabitants registered in the census, of which
13.78% were members of the immigrant population (1,041,362 inhabitants). Within the for-
eign population, 26.64% come from the Americas (277,435 inhabitants) [10]. Specifically, in
2017, the Bolivian population with residence permits in Catalonia was 30,655 people, of which
23,148 live in the province of Barcelona [10]. This shows a clear increase in the population of
this group in our surroundings in the last decade; in 2007, 17,900 Bolivians lived in Catalonia,
specifically 14,074 in the province of Barcelona. A total of, 9063 Bolivians were registered in
the census within Barcelona’s city limits in 2017, which is less than those that lived there in
2007 (16,352) [11].
Community intervention strategies
The process of construction of the community strategies (2004–2013). From the year
2002–2004 the first cases of CHD in our surroundings were detected in a significant way, a dis-
ease which, until then, had not been detected in Catalonia [12].
The work began in 2004 with a clinical approach [13], followed by a socio-anthropological
approach [5,14]. Once the situation was understood more deeply, an approach was begun
from the public health field. This contributed to the creation, product of previous work, of the
Asociación de Amigos de las personas afectadas por la enfermedad de Chagas (ASAPECHA,
Association of Friends of Chagas affected Patients), which allowed for collaborative work to
begin between primary care and specialized care. Subsequently a phase of integral approach
started, incorporating the psycho-social aspects of the disease with clinical work. The cycle fin-
ished with a global approach proposal and with the definition of the best strategies to use, both
in the improvement of access and in the management of clinical examination (Table 1).
Implementation of the strategies to improve the access to diagnosis and treatment of
Chagas Disease: Community interventions (2014–2017). The community interventions
completed in this period have been organized into three groups: workshops, community
events, and in situ screenings. The plan for these strategies was made by the community health
team and integrated by a doctor, two nurses, and the community health agents (CHA). The
CHA had also leaded the interventions accompanied on occasion by educators of community
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peers and/or multipliers. The whole community health team has been involved in all the inter-
ventions. CHA have been professionally trained as social mediators and also received specific
training on community health. Community peers have been trained on Chagas disease by
healthcare professionals within the community health team. Both, CHA and community peers,
have played an important role in the implementation of the different strategies, by hosting
workshops, informing in community events and facilitating in situ screening interventions.
These three proposed strategies are established according to:
1. The collective organization of the Latin American community, specifically Bolivians, living
in Barcelona, which occurs mainly around leisure-cultural events.
2. The community health team observations regarding the strategies which had better accept-
ability among the Latin American community, specifically Bolivians, and that lead to an
increased accessibility to the diagnosis and treatment of the affected people
3. The revised literature for the community approaches to tackle health problems, in which
integrating an IEC approach promotes better results.
The workshops were organized thanks to the collaboration and involvement of different
organizations and associations. The hosts of the workshops were the CHA. The group of par-
ticipants was closed, with a maximum of 15 participants per workshop. The workshops lasted
for one hour and they aimed to inform and educate. The material used was the result of work
done during previous stages, such as that of the platform BeatChagas (www.beatchagas.info)
[15].
In addition, there were the community events interventions, which involved CHA and peer
educators. The objective was to get close to the population that is susceptible to contracting
CHD by giving information about the disease at cultural events or crowded meetings
(Table 2).
Finally, the in situ screening interventions went a step further than community events by
bringing both health information and screening closer to this susceptible population during
their free time. This made easier for patients to take the test without having to travel far or go
to the health center during their working hours.
Table 1. Stages of the construction and implementation process of the community strategies for improvement of access to diagnosis and treatment of Chagas
disease in Catalonia: Approaches and objectives.
2004–2013 2014–2017
Construction of Community Strategies Implementation of the
community strategies2004–2005 2006–2007 2008–2009 2010–2011 2012–2013
Clinical Approach Socio-Anthropological
Approach
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https://doi.org/10.1371/journal.pone.0235466.t001
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Microbiological testing and follow-up
The microbiological testing of the blood samples obtained during screening has been per-
formed using one recombinant antigen EIA (CHAGAS ELISA IgG+IgM, Vircell, Spain). All of
the samples with an index >0.9 were also tested simultaneously for one lysate antigen EIA
(ORTHO Trypanosoma cruzi ELISA Test System, Johnson and Johnson, USA). Both tech-
niques had to be concordant in with an index >0.9, to be considered a reactive serology. After
the confirmation of a positive result, the CHD contacted the patients by phone or by person to
attend the USIDVH. Access to antiparasitic treatment for CHD is universal in our healthcare
setting, so patients were able to start their treatment just after their first clinical visit. They
received cardiac and digestive tests in this first visits, to now the extension of CHD. Patients
received medical and bio-psychosocial follow-up during the treatment and afterwards, first on
a week basis and afterwards every 15 days.
Statistical analysis
The analysis of the interventions was completed through Stata v14 (StataCorp. 2015. Stata Sta-
tistical Software: Release 14. College Station, TX: StataCorp LP). A univariate analysis was per-
formed to describe the main characteristics of the participants in the different interventions.
The interventions were compared to each other using the Pearson’s chi-squared test, according
to the number of the participants, the number of the screened persons and the result obtained
in the screening test.
Table 2. Description of the different developmental phases of the implemented community strategies.
Workshops Community Events In Situ Screening
Recruitment and
preparation
Different organizations are contacted and
meetings are set up to establish a network of
contacts.
Interested parties are contacted (in person or by
phone) to attend the workshop.
The event is chosen and the organizers are contacted.
The necessary logistics for the event are prepared: personal (healthcare professionals, CHA,
community multipliers), along with educational and other materials.
A mobile unit for blood sampling is also




The workshop is conducted on the property of
an association or at USIDVH.
The general characteristics of Chagas disease and
its impact at different levels is discussed, using
materials from www.beatchagas.info. When the
workshop is finished, the participants are offered
the possibility of being screened for Chagas at
USIDVH or other health centers in Barcelona.
An informative stand is set up at the event, at which the CHA and community multipliers
inform others about the activity and Chagas disease.
People are informed about Chagas
disease and the possibility of screening
for Chagas at USIDVH or in other health
centers in Barcelona.
People are informed about the disease and given
surveys to assess their prior knowledge.
Those that wish to be screened are accompanied
to the mobile unit, where healthcare
professionals conduct an interview.
Scheduling and
screening
The professionals take note of the information of those who want to be screened, to contact
them afterward.
Visits are scheduled after contacting patients by phone. The visit to USIVDH occurs,
following the normal protocol for Chagas disease screening. Blood samples are taken and
processed in the laboratory. The patients are scheduled for follow-up visits to get their
results.
Blood samples are taken and processed by the
USIDVH lab. The patients are told that they will
receive a phone call from USIDVH about the




The blood samples are processed in the microbiology lab at the Vall d’Hebron University Hospital.
Follow-up is conducted according to the results obtained1:
• When the test is negative, the patient is contacted by phone and informed.
• When the test is uncertain (one test positive and the other negative) the patient is scheduled and a new blood test is performed.
• If the test is positive, the patient is scheduled at USIDVH to undergo supplementary tests to determine the possibility of cardiac and/or
digestive affectation, begin antiparasitic treatment, and follow-up.
1The positive diagnosis is based on the consistency of two different and simultaneous techniques for the detection of anti-trypanosoma antibodies: one with a
recombinant antigen (r-ELISA: Bioelisa Chagas Biokit, España) and another with an antigen lysate ORTHO T. cruzi ELISA, Johnson & Johnson, USA).
CHA—Community Health Agents; USIDVH—International Health Unit Drassanes-Vall d’Hebron.
https://doi.org/10.1371/journal.pone.0235466.t002
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Ethics statement
All participants gave oral consent to participate to the interventions and were actively enrolled
to the community interventions once they received information about the activity. All patients
who were screened gave oral consent to undergo the screening test as part of the health center’s
routine screening protocol for CHD. Each patient’s consent was documented in their comput-
erized medical history. The procedures performed during the screening are the ones recom-
mended by the WHO. Data were analyzed after the completion of all the activities as a
retrospective comparative analysis. Patients’ written consent was not possible to be obtained
retrospectively because it was difficult to contact all of them. All patients’ data were codified
and analyzed anonymously. No data containing personal or identifying information from the
participants have been published. Vall d’Hebron Hospital Ethics Committee approved the
study as a report of the results derived from regular clinical practice.
Results
Construction process of the community strategies (2004–2013)
2004–2005: Clinical approach. Between 2004 and 2005 the first diagnosis of CHD in Bar-
celona were made, through a process of protocol, in the frame of a research project [13]. In
this multi-focused study, an elevated percentage of participants were found to be infected with
T. cruzi (41% of the total of participants in the study and up to 65% of the participants who
were Bolivian) [13], demonstrating the existence of the disease in the area and its repercussions
on public health.
This fact subsequently led to the publication of a document in consensus that was related to
the diagnosis and treatment of imported CHD [16] in our surroundings in 2005. This docu-
ment highlights the need to screen for T. cruzi in blood banks and in pregnant women. The
document also shows the importance of working on awareness and training of health profes-
sionals to be relevant to carrying out the screening in health centers that specialize in tropical
medicine. Likewise, in the following years, recommendations were published about possible
cardiac and digestive effects [17,18].
2006–2007: Socio-anthropological approach. After the clinical approach and its phases
have been defined, the need to provide psyco-social support to these patients was detected [19]
as a consequence of the daily assistance given to affected people and their family members.
Between 2006 and 2008 a qualitative study was performed with the goal of understanding the
meaning of CHD for Bolivian people in a migratory context [5]. From this study, several key
themes were highlighted: the perception of inevitable death related to CHD, the fear of receiv-
ing the diagnosis of the disease, and, consequently, the limited willingness of patients to per-
form CHD diagnosis tests. The close link that is formed between death and CHD made it
essential to question and revise how we establish contact between the patient and the health
system, given that there is a confirmed lack of access from a social point of view.
2008–2009: Approach from the fields of community health and public health. The for-
mation of ASAPECHA in Barcelona in 2008 made it possible to unite carriers of the disease,
family members, friends, and people with CHD. It guaranteed access to information about
integral treatment in health and social services in a non-endemic context. At the same time,
communication networks between the healthcare systems in the countries of residence and
countries of origin were promoted. In addition, the existing communication and information
networks throughout the world were reinforced by emerging new groups of affected people,
such as the group in Barcelona, to promote a coordinated effort.
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On February 24th, 2008, the publication of the news article “Chagas: The Silent Disease” in
the newspaper El Latino, distributed in Spain, caused a rise in visits to USIDVH by people who
come from areas where CHD is endemic, along with a rise in the number of diagnoses of CHD.
That summer, another activity was held about the spread of the disease and the importance of
screening during the Bolivian Heritage Festival, at the ASAPECHA/eSPiC stand. During this
period, the Government of Catalonia began the compilation of the “Protocol for screening and
diagnosing Chagas disease in pregnant Latin American women and their newborns” [20]. The
Catalan Institute of Health (ICS), the leading healthcare service provider in Catalonia, also expe-
dited requests for serology in the face of T. cruzi for all family doctors in the primary healthcare
network. In addition, the clinical pathways were consolidated and screening protocols were
stablished for people suspected of suffering from CHD [16,17,19–22].
2010–2011: Integral approach. In this period, activities started being held during public
community events and educational materials were produced in collaboration with institutions
that specialize in the health field, predominantly eSPiC of USIDVH [23]. The work of previous
stages was also consolidated by the participation of health professionals, eSPiC, and ASAPE-
CHA in five celebrations put together by Latin American communities in the city of Barcelona.
These three entities also monitored patients, not only at the clinical level but also at the psy-
cho-social level.
In the year 2010, FINDECHAGAS (International Federation of Associations of People
Affected by Chagas Disease) was created, a federation in which ASAPECHA participated
regularly.
In Catalonia in 2011 the ICS [24] implemented the “Expert Patient in Chagas Disease Pro-
gram” with the support of the WHO. The methodology that was followed in the sessions was
established in the protocol of the “Expert Patient Program”[25], which has been used for other
diseases and was adapted to the distinct features that CHD has. In this program, a patient with
a diagnosis of CHD, trained with the eSPIC team, acts as an “expert patient” and trains and
guides a group of newly affected patients. The goal of these sessions was for peers to inform
and educate each other about CHD and to increase the knowledge and self-esteem of recently
diagnosed participants. Furthermore, the sessions achieved greater participation and involve-
ment of people in CHD awareness, either through ASAPECHA or through their participation
in different community interventions.
2012–2013: Global approach. In April of 2012, the project PROSEVICHA (Project to Pro-
mote Awareness through Visualizing the Reality of People Affected by Chagas Disease) was pre-
sented. Its goal was to make the public aware of the reality of people affected by CHD by
showing the complex problems that affected people experience in different contexts with
regard to access to diagnosis and treatment. To achieve this goal, different songs were prepared
along with two publicity videos [15].
On April 14th 2013, the “First Commemoration of the International Chagas Disease Day in
Barcelona” was held, together with ASAPECHA, FINDECHAGAS, and the MundoSano-
España Foundation. At this event, which was held at the USIDVH, two parallel strategies were
used: one for screening people who came from endemic countries, and another for promoting
awareness and information for representatives of social, political, and healthcare entities. This
way made it easier to promote access to diagnosis among the Latin American immigrant popu-
lation, and to spread awareness of the importance of diagnosis and control at the individual,
group, community, and institutional levels.
The event was publicized in places where socialization among the Latin American popula-
tion is common (primary care centers, international phone booths, bars). Informative pam-
phlets, word of mouth, communication media (radio, websites), and invitations to
representatives of those entities were used to spread word of the events. This was done with
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the support from healthcare personnel, administrative personnel, CHA, and members of
ASAPECHA.
Process of implementing strategies to improve access to diagnosis and treatment of
Chagas Disease: Community interventions (2014–2017). The three community interven-
tions that are described below were established as a result of the work done previously between
2004 and 2013 (Table 1). Between 2014 and 2017, 1,621 people in the city of Barcelona received
intervention by the USIDVH, of which 1,101 (67.92%) underwent the diagnostic screening
test for T. cruzi. Of all the people screened, 196 people (17.80%) have been diagnosed with
CHD. More women than men participated in the different community strategies imple-
mented. The majority of the participants (82.79%) were from Bolivian origin (Table 3).
Between 2014 and 2017, 41 workshops were performed in community centers and health cen-
ters. In total there were 313 attendees, of whom 87.54% (274 of 313) requested an appointment
to be visited at the USIDVH. A total of 58.03% of the patients (159 of 274) were screened,
being CHD diagnosed in 33 people (20.75%) after two positive blood tests for T. cruzi.
USIDVH and eSPiC also participated in 12 community awareness campaigns between 2014
and 2017: celebrations of Bolivian Mother’s Day, the Festival of the Alasitas, and the Consulate
Table 3. Summary of the results obtained in the different community strategies implemented between 2014–2017.




Workshops 1 Total n % n % n % n % n %
9 workshops (2014) 70 47 67.14 57 81.43 54 77.14 37 68.52 7 18.92
7 workshops (2015) 42 25 59.52 23 54.76 34 80.95 28 82.35 7 25.00
9 workshops (2016) 68 41 60.29 49 72.06 61 89.71 29 47.54 3 10.34
16 workshops (2017) 133 119 89.47 83 62.41 125 93.98 65 52.00 16 24.62
Global 313 232 74.12 212 67.73 274 87.54 159 58.03 33 20.75
Persons per intervention 7.63 5.66 5.17 6.68 3.88 0.80
Community events 2 Total n % n % n % n % n %
3 events (2014) 28 28 100.00 17 60.71 27 96.43 7 25.93 5 71.43
3 events (2015) 108 98 90.74 64 59.26 72 66.67 30 41.67 6 20.00
3 events (2016) 95 85 89.47 63 66.32 86 90.53 32 37.21 9 28.13
3 events (2017) 121 94 77.69 85 70.25 89 73.55 43 48.31 5 11.63
Global 352 305 86.65 229 65.06 274 77.84 112 40.88 25 22.32
Persons per intervention 29.33 2.42 19.08 22.83 9.33 2.08
In situ screening 3 Total n % n % n % n % n %
1 intervention (2014) 181 139 76.80 131 72.38 131 100.00 35 26.72
1 intervention (2015) 264 264 100.00 166 62.88 264 100.00 264 100.00 45 17.05
1 intervention (2016) 164 164 100.00 98 59.76 164 100.00 164 100.00 34 20.73
2 interventions (2017) 347 238 68.59 193 81.09 271 78.10 271 100.00 24 8.86
Global 956 805 84.21 830 86.82 830 100.00 138 16.63
Persons per intervention 191.20 161.00 166.00 166.00 27.60
1.Workshops were performed in health centers and in community centers. In the year 2014, the participants were from 9 different countries. In 2015, the participants
were from 6 different countries while in 2016 from 10 and in 2017 from 4 countries. Those countries were: Venezuela, Ecuador, Perú, Honduras, Nicaragua, El Salvador,
Colombia, Argentina, Dominican Republic, Paraguay and Puerto Rico.
2.In 2014, the participants in the community events where only from Bolivia, while in 2015, 2016 and 2017 they came from 6 different countries: Ecuador, Perú,
Colombia, Paraguay, México and Spain.
Data on patients visited at USIDVH and screened for Chagas disease are the same as the in situ screening intervention was performed in a mobile unit from USIDVH.
For 2014 intervention, no data on gender are available. In 2015, interventions were only among people from Bolivian origin.
https://doi.org/10.1371/journal.pone.0235466.t003
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of Bolivia in Barcelona’s Open House Day. In total, 352 people were informed, of whom
77.84% (274 of 352) requested appointments at our unit afterward. A total of 112 of those peo-
ple (40.88%) were screened, and a positive result (and consequently a diagnosis of CHD) was
obtained in 25 people (22.32%). During this period, five efforts were made to screen for CHD
in situ interventions: at the Bolivian Heritage Festival from 2014–2017 and at a concert for the
Bolivian group Los Kjarkas in 2017. In total 956 people were reached and 830 of them
(86.82%) were screened. CHD was confirmed in 138 patients (16.63%). The coverage, or num-
ber of people reached, is different in each of the three proposed strategies; the greatest coverage
was observed in the in situ screening interventions (956 persons, 58.98%) (Table 3).
The results obtained show that the number of people who request an appointment after
doing the workshop is higher than those who do so after community events (87.54% and
77.84%, respectively), despite the fact that no significant differences wereobserved (p-value =
0.309). Clear differences do exist between the three strategies in terms of the percentage of
screening tests carried out (p-value<0.001). The largest number of patients screened occurred
atthe in situ screening interventions; the lowest number occurred in the community events,
with 112 people screened (40.88%). However, the greatest number of diagnoses was made
among the participants in community events and workshops (25 and 33 persons respectively,
22.32% and 20.75% of those screened respectively). The prevalence of infection found is simi-
lar among the three strategies, ranging from 16.63% to 22.32% of the screened patients, with
no significant differences (p-value = 0.325) (Table 3).
It is worth highlighting that there was a higher percentage of women participating in the
different interventions conducted compared to men, ranging from 54.76% to 81.43, with no
statistical differences regarding the type of intervention (p-value = 0.743) (Table 3).
Discussion
The first years of work (2004–2013) fostered the establishment and reinforcement of the three
types of community interventions thatwork was focused during subsequent stages. The
increase in disease detection and parallel improvement in the quality of both individual and
collective care, which were both results of the different approaches taken initially, were deter-
minant factors in decidingon the community interventions to be carried out starting in 2014.
The final goal was integral care for people affected by CHD by cultivating an improvement in
their quality of life [7], as has been observed.
The results obtained in the three community interventions (workshops, community events,
and in situ screenings) conducted starting in 2014 show differences between each other regard-
ing the number of participants and the total of screenings performed, although those differ-
ences were not statistically significant. The participants that the interventions focused on were
principally of Bolivian origin, since previous studies in Europe verify that there is a higher
prevalence of CHD in this group [3,26].
We observed a larger percentage of women participating in all of the interventions con-
ducted. Other publications had already shown that there was more participation among
women than men, both in the awareness events and in their interest and need to perform the
screening in relation to Chagas [24,27,28]. According to previous studies, women show more
concern and interest in screening, mainly because of feelings of guilt, worry, and responsibility
for the potential transmission of the disease to their children [5]. As congenital transmission of
CHD is well known and women are conscious of it, this may lead to and increased participa-
tion of women in the interventions which is also crucial to control this way of transmission.
The potential number of people reached depends on the chosen strategy. The in situ screen-
ing interventions allow us to reach a greater number of people, but also require a greater effort
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in terms of people and organization, as can be observed in Table 2. Likewise, the community
events allow more people to be accessed even though the event is limited to being informative-
educational because of the lack of possibility of in situ diagnosis; with the idea of setting up an
appointment later on. In reference to the workshops, the investment of time is higher and
fewer people are reached. Nevertheless, the results obtained show that the percentage of people
who request an appointment after doing the workshop is higher than those who do so after
community events (87.54% vs 77.84%, respectively), even though no significant differences
have been observed (p-value = 0.309). This suggests that the workshops, since they are an edu-
cational activity with fewer participants, allow for greater understanding of the disease and its
current predicament and, at the same time, allow for a more detailed follow-through with
scheduling appointments. At the community events, educational actions are more difficult,
since we must speak to many more people over a smaller period of time, limiting it to an action
that is merely informative without follow-up.
Regarding access barriers to screening, the interventions were performed were adapted to
suit the community. They were done close to the homes and workplaces of the Latin American
community during non-working regular hours, thus facilitating access of those who were
interested. Relevant differences are made evident among the three community interventions
in terms of completion of the screening. In the case of in situ screenings, the percentage of
screened people was higher than that observed in the rest of the interventions. This is because
the main objective of this type of interventions is to complete the screening in a specific popu-
lation at the time of intervention, with the overall goal of improving follow-up and adherence
of the patients to their integral treatment. When the patients undergo the diagnostic test in the
intervention, they are closely linked to their follow-up treatment. Once the screening test had
been performed, the results were given by phone call, minimizing the number of visits at the
clinic. In case of positive result and need of treatment and follow-up visits, clinic schedules
were very adaptable to patients. The patients with a positive result were given a medical
appointment in our clinic, having been located and advised by the same community healthcare
team that had intervened at the events. This helps form bonds of trust and cultural adaptation,
which had already begun at the festival
In the different published studies, we observed difficulty with both recruitment and follow-
through. In a study conducted in Italy, 1305 people were screened as a result of screening
workshops. Of those screened, 223 people (17%) had Chagas, and there was a large number of
patients lost in the follow-through [28].
In relation to follow-up and the benefit of the intervention on the part of the community
health team, the study completed in Barcelona in the frame of the congenital CHD program
showed that of the total number of newborns that should have been screened according to pro-
tocol, 42 (24%) were not screened. The team of CHA, through community interventions,
recovered 30 of them, leaving only 7% of patients who still needed the screening recommended
in the protocol [29]. Another study done in Madrid shows how out of 352 participants in rele-
vant talks, 276 (78.4%) were tested immediately for T. cruzi [30].
Because of these facts, in our interventions we observed a higher percentage of people
screened during the in situ screening, followed by the workshops (58.03%), and finally by the
community events (40.88%). This suggests again that the educational piece behind the screen-
ings and workshops is better than that of the community events, reinforcing the idea that the
community events are limited to being simply informative actions. The fact that CHD it is a
disease in which psycho-social aspects play such a relevant role means that it is very necessary
to approach it from an educational point of view, to transform a collective conscience affected
by stigmas brought from the past. Also, the higher number of persons screened in the in situ
screening interventions shows that facilitating the access to screening tests, as performing
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them in cultural/social events and in non-working days, increases the accessibility to poten-
tially CHD affected patients.
Finally, the prevalence of disease in the three types of interventions are similar (p-value =
0.325), although there are differences that deserve to be highlighted. We observed a prevalence
of 22.32% (95% CI: 14.99–31.16%) in the community events; of 20.75% in the workshops (95%
CI: 14.74–27.89%); and of 16.63% in the in situ screening (95% CI: 14.15–19.33%).
Previous studies conducted in Catalonia by the Catalonian Blood Bank showed a seropreva-
lence of T. cruzi infection of 10.2% in Bolivian donors [31]. In published studies, the preva-
lence of CHD observed among the Bolivian population living in Europe is 18.1% (95% CI:
13.9–22.7%), which differs from the prevalence of the rest of the Latin American population
that lives in the territory in which is 4.2% (95% CI: 2.2–6.7%) [26]. In Spain, a prevalence of
27.7% has been described among Bolivian population [27]. The higher prevalence observed in
our study, compared to the seroprevalence study among Bolivian donors, is attributable to the
fact that our interventions were designed to reach at-risk patients, where self-considered
patients at risk will be more likely to attend to the interventions and to the screening. Since
there was little informative time and minimal educative action in community events, only
those that seemed most at risk of being affected were reached. This means that there could be a
selection bias in the intervention and that the other interventions could carry the same self-
selection.
The collaborative work between team members facilitates the implementation of the above-
mentioned strategies, complementing clinical and social aspects. CHA are responsible for
establishing social networks and contacts; expert patients/peer educators are in charge of
informing and educating the participants; public health nurses and doctor take care of the
strategy and its implementation; and the clinical team handles the clinical aspects, including
diagnoses, treatment and follow-up. We believe that the success of our interventions owes itself
to the fact that eSPiC relies on a team of CHA that understand the particular features of the
Latin American community, specifically the Bolivian community, and knows their social net-
works and meeting places. Therefore, they were able to get past some of the psycho-social bar-
riers that impede the population that is susceptible to suffer from CHD from accessing
necessary medical attention [32]. Additionally, the “expert patients” and the peer educators
completed the effort by approaching the needs and perceptions of the population that is likely
to suffer from CHD. All those involved in the planning and execution of the strategies played
key roles, and without them it would not have been possible to achieve such successful results.
These interventions have been set within a more integral framework of information, educa-
tion and communication which has been conducted since the very beginning of the present
study in eSPiC, becoming education necessary to overcome these psycho-social barriers [33].
Programs like this have also been used successfully for other diseases such as HIV in adoles-
cents and in other types of healthcare, such as primary care and mother/child healthcare [34–
36]. This suggests that the presence of CHA improves the effectiveness of the community
interventions.
As for the limitations of the study, it should be noted that we do not have information on
the total number of attendees at the community events in which in situ screening interventions
were performed. Data collection was planned after the project began, so some variables that could
have been of great interest were not gathered, such as: age and sex, both in those visited at
USIDVH but also among those screened or affected by CHD; number of pregnant women partic-
ipating in the different interventions; country of origin; socioeconomic and demographic data;
etc. This information is very difficult to collect retrospectively. In this sense, data were also not
registered systematically and prospectively, causing missing information. If the data collection
had been done in a way that made this information available, the study would be much more
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informative and the impact could be assessed in a more accurately. There is also some possible
bias present in this study regarding missing information, as the populations in the different inter-
ventions are assumed to be comparable and they may not be. Considering that the majority of the
participants were from Bolivia, the results obtained may be interpreted cautiously when extrapo-
lating to other endemic countries, as socio-demographic characteristics may be different.
In our context, the migratory experience transforms the perception that people have of
themselves and of CHD [19]. It is important to prevent people from being stigmatized once
they contract the disease, since this can reinforce the process of social exclusion. For this rea-
son community work becomes very important, as it helps reverse these perceptions and social
exclusion. Active and organized participation of affected patients contributes significantly in
the prevention and awareness of the disease.
The characterization of the different community interventions available to increase detec-
tion of cases of CHD, based on the context and the reality of the different populations, is an
opportunity to optimize the different screening strategies. It is necessary to adjust resources
and improve efficiency in order to increase the number of patients diagnosed and improve the
follow-up care of those affected.
The choice of the strategy should consider different aspects, such as the possibilities in
terms of resources and knowledge of the teams involved, the available social network, the pres-
ence of civil society organizations, the barriers on access to healthcare for those affected
regarding their administrative situation, etc. Nevertheless, our results suggest that when the
prevalence of CHD is unknown in the targeted groups, the community event strategy should
be prioritized because it allows reaching a large and diverse audience, to access equal or better
prevalence of disease, and it requires fewer people and materials for the intervention, which
should be less expensive and more effective. When the prevalence of CHD in a certain popula-
tion is known to be high, the most adequate strategy is the in situ screening, along with the
workshops using CHA, peer educators, community leaders, and associations. In our opinion,
it would be advisable to conduct cost-efficiency studies to better understand, and be able to
exactly quantify, the cost of these interventions related to their impact in accordance with the
prevalence of disease in a specific environment.
Conclusion
The community intervention strategies in different non-endemic contexts should be adapted,
both in their preparation and their execution, to the characteristics of each context.
An intervention based on the community that involves community health teams, including
health professionals, CHAs and peer educators can be more effective than the habitual routine
of health centers. This is because of the psycho-emotional and socio-anthropological charac-
teristics of CHD, and because of the fact that the community health teams, CHA and peer
educators are experts in this approach and have access to resources and strategies that are ade-
quate in this situation.
These approaches allow for bonds of mutual trust between professionals and the commu-
nity that could be helpful in the future development of health promotion strategies.
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Writing – original draft: Jordi Gómez i Prat, Paula Peremiquel-Trillas, Pedro Albajar Viñas.
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12. Gómez i Prat J, Claveria Guiu I, Treviño B, Manzardo C, Navarro R. Enfermedad de Chagas en Europa:
¿una realidad creciente? Estudio epidemiológico de los casos diagnosticados en la Unitat de medicina
Tropical i Salut Internacional Drassanes de Barcelona entre Octubre 2002 y Enero 2004. Enferme-
dades infecciosas importadas y emergentes, inmigración, casos clı́nicos. IV Congreso de la Sociedad
Española de Medicina Tropical y Salud Internacional (SEMTSI). Valencia, 18 a 22 de julio de 2004.
Enfermedades Emerg. 2004; 6(3):143–56.
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